Perimeter Solutions announced on January 22 that it has closed a $685 million cash acquisition of Medical Manufacturing Technologies LLC (MMT) from Arcline Investment Management. The deal was financed with cash on hand and proceeds from a $550 million senior secured notes offering that closed on January 2, 2026, giving the company a net leverage ratio of roughly 2.7× net debt to combined adjusted EBITDA.
MMT is a leading provider of highly engineered machinery and aftermarket consumables for the manufacturing of minimally invasive medical devices. In 2025, the company generated $140 million in revenue and $50 million in adjusted EBITDA, implying an enterprise‑value to EBITDA multiple of 4.9× and an enterprise‑value to revenue multiple of 13.7×. About half of MMT’s revenue comes from aftermarket services, a recurring, high‑margin stream that aligns closely with Perimeter’s Specialty Products segment.
The acquisition expands Perimeter’s footprint into the medical device manufacturing equipment sector, adding a new high‑margin revenue stream and complementary aftermarket capabilities. The financing structure—cash and senior notes—raises the company’s leverage but is considered manageable because MMT’s projected cash flow is expected to support the debt load. Analysts note that the 2.7× leverage level is higher than Perimeter’s historical range but still within the company’s risk tolerance.
CEO Haitham Khouri said the deal is an “excellent fit” that will “seamlessly integrate into our decentralized operating structure.” CFO Kyle Sable highlighted that MMT’s secular growth trajectory and strong free‑cash‑flow generation fit Perimeter’s strategy of acquiring businesses with durable earnings power. Both executives emphasized that the aftermarket component will provide a steady, recurring revenue base that can offset the cyclical nature of equipment sales.
Investor sentiment has improved following the announcement, with a significant drop in short interest reported in the days after the deal. Market analysts view the acquisition as a strategic pivot toward higher‑margin, recurring‑revenue businesses, while noting the increased leverage as a potential headwind. The transaction is expected to enhance Perimeter’s competitive position in the medical technology manufacturing space and to accelerate growth in its Specialty Products segment.
Overall, the acquisition positions Perimeter to capture a growing market for minimally invasive medical device manufacturing equipment, while the strong aftermarket business provides a resilient revenue stream. The deal’s financial terms and strategic fit suggest a positive long‑term impact on the company’s earnings quality and capital structure, albeit with a modest increase in leverage that management believes can be comfortably serviced by MMT’s cash flow.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.